Sanofi (NASDAQ:SNY) Position Raised by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky increased its position in Sanofi (NASDAQ:SNY - Free Report) by 7.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 409,290 shares of the company's stock after buying an additional 27,330 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Sanofi were worth $19,740,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. State Street Corp boosted its position in shares of Sanofi by 0.5% in the third quarter. State Street Corp now owns 56,734 shares of the company's stock worth $3,270,000 after buying an additional 264 shares during the period. Barclays PLC boosted its holdings in Sanofi by 107.5% in the 3rd quarter. Barclays PLC now owns 639,772 shares of the company's stock worth $36,869,000 after acquiring an additional 331,445 shares during the period. Geode Capital Management LLC grew its position in Sanofi by 7.1% in the third quarter. Geode Capital Management LLC now owns 254,738 shares of the company's stock valued at $14,681,000 after acquiring an additional 16,780 shares in the last quarter. World Investment Advisors LLC raised its stake in shares of Sanofi by 1,020.5% during the third quarter. World Investment Advisors LLC now owns 48,430 shares of the company's stock valued at $2,791,000 after purchasing an additional 44,108 shares during the period. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Sanofi during the third quarter worth $219,000. 14.04% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on SNY. The Goldman Sachs Group assumed coverage on shares of Sanofi in a research note on Friday, March 21st. They set a "neutral" rating and a $65.00 price target on the stock. BNP Paribas assumed coverage on shares of Sanofi in a research note on Tuesday, April 15th. They issued an "outperform" rating and a $65.00 price target for the company. Sanford C. Bernstein upgraded shares of Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a "sell" rating to a "hold" rating in a report on Thursday, January 30th. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $63.33.

Sanofi Stock Performance

Shares of SNY stock traded down $1.22 on Friday, hitting $52.32. 5,488,689 shares of the stock traded hands, compared to its average volume of 2,372,473. The company's fifty day moving average is $54.53 and its 200 day moving average is $52.09. Sanofi has a 1-year low of $45.80 and a 1-year high of $60.12. The company has a market capitalization of $132.17 billion, a PE ratio of 21.01, a PEG ratio of 1.01 and a beta of 0.57. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14.

Sanofi (NASDAQ:SNY - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $0.94 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.04. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. The company had revenue of $10.41 billion for the quarter, compared to analysts' expectations of $9.79 billion. On average, equities research analysts predict that Sanofi will post 4.36 earnings per share for the current fiscal year.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, June 12th. Shareholders of record on Friday, May 9th will be paid a $2.0369 dividend. This is an increase from Sanofi's previous annual dividend of $1.48. This represents a yield of 3.1%. The ex-dividend date is Friday, May 9th. Sanofi's payout ratio is presently 57.14%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.